Dr. Kristopher J. Kimball, MD

Dr. Kimball practices at The University of Tennessee Medical Center in Knoxville, Tennessee, part of Ut Medical.

Dr. Kimball's NPI, 1073721635, was assigned on May 18, 2007. Dr. Kimball graduated from Vanderbilt University School of Medicine in 2003. Dr. Kimball holds Tennessee license 45968.

Dr. Kimball's primary practice is The University of Tennessee Medical Center, at 1924 Alcoa Highway, Knoxville, TN 37920 in Knox County. The practice phone is (865) 305-9000.

Dr. Kimball's primary practice is The University of Tennessee Medical Center in Knoxville, Tennessee, part of Ut Medical. The medical group on file is UT Internal Medicine - Pellissippi. Dmand AI also links Dr. Kimball to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kimball practices, 2 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Kimball's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Kimball is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dr. Kimball is licensed in Tennessee.

CMS data shows 527 Medicare services from Dr. Kimball across 10 procedure codes in 2024, for 168 Medicare patients. Medicare paid $46,079 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 168 Medicare patients who saw Dr. Kimball in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kimball's median patient age at 67, with 99% women.

In 2024, Dr. Kimball wrote 105 Medicare Part D claims for 45 patients. 87% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $437 in total drug cost. In 2022, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Kimball for performance year 2024, reported through an alternative payment model (APM). Dr. Kimball accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of removal of the uterus by Dr. Kimball, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Kimball, published from 2012 to 2024. Dr. Kimball's most frequent co-authors are Larry C. Kilgore, MD, Jonathan David Boone, MD and Ronald D. Alvarez, MD.

CMS Open Payments shows 243 general payments to Dr. Kimball from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Intuitive Surgical, Inc. paid the most, $1,470.

Dr. Kimball graduated from Vanderbilt University School of Medicine in 2003.